Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SULBACTOMAX vs ceftriaxone in hospitalized adults with community-acquired pneumonia
KCT0000745Phase 3Recruiting
- Sponsor
- Korea Pharma
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulbactam, ceftriaxone in community-acquired pneumonia (CAP), sponsored by Korea Pharma. Started Jul 2012; status: recruiting.
02
Drugs
sulbactamceftriaxone
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on KCT0000745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000745.